BACKGROUND During aging, there is a functional decline in the pool of muscle stem cells (MuSCs) that influences the functional and regenerative capacity of skeletal muscle. Preclinical evidence has suggested that nicotinamide riboside (NR) and pterostilbene (PT) can improve muscle regeneration, e.g., by increasing MuSC function. The objective of this study was to investigate if supplementation with NR and PT (NRPT) promotes skeletal muscle regeneration after muscle injury in elderly individuals by improved recruitment of MuSCs.METHODS Thirty-two elderly individuals (55–80 years of age) were randomized to daily supplementation with either NRPT (1,000 mg NR and 200 mg PT) or matched placebo. Two weeks after initiation of supplementation, skeletal muscle injury was induced by electrically induced eccentric muscle work. Skeletal muscle biopsies were obtained before, 2 hours after, and 2, 8, and 30 days after injury.RESULTS A substantial skeletal muscle injury was induced by the protocol and associated with release of myoglobin and creatine kinase, muscle soreness, tissue edema, and a decrease in muscle strength. MuSC content, proliferation, and cell size revealed a large demand for recruitment after injury, but this was not affected by NRPT. Furthermore, histological analyses of muscle fiber area, central nuclei, and embryonic myosin heavy chain showed no NRPT supplementation effect.CONCLUSION Daily supplementation with 1,000 mg NR and 200 mg PT is safe but does not improve recruitment of the MuSC pool or other measures of muscle recovery in response to injury or subsequent regeneration in elderly individuals.TRIAL REGISTRATION ClinicalTrials.gov NCT03754842.FUNDING Novo Nordisk Foundation (NNF17OC0027242) and Novo Nordisk Foundation CBMR.
Jonas Brorson Jensen, Ole L. Dollerup, Andreas B. Møller, Tine B. Billeskov, Emilie Dalbram, Sabina Chubanava, Mads V. Damgaard, Ryan W. Dellinger, Kajetan Trošt, Thomas Moritz, Steffen Ringgaard, Niels Møller, Jonas T. Treebak, Jean Farup, Niels Jessen
Title and authors | Publication | Year |
---|---|---|
Program with last minute abstracts of the Padua Days on Muscle and Mobility Medicine, 27 February – 2 March, 2024 (2024Pdm3)
Zampieri S, Bersch I, Smeriglio P, Barbieri E, Boncompagni S, Maccarone MC, Carraro U |
European Journal of Translational Myology | 2024 |
Channeling Nicotinamide Phosphoribosyltransferase (NAMPT) to Address Life and Death
Velma GR, Krider IS, Alves ET, Courey JM, Laham MS, Thatcher GR |
Journal of Medicinal Chemistry | 2024 |
Regulation of and challenges in targeting NAD(+) metabolism.
Migaud ME, Ziegler M, Baur JA |
Nature reviews. Molecular cell biology | 2024 |
Effect of nicotinamide riboside on airway inflammation in COPD: a randomized, placebo-controlled trial.
Norheim KL, Ben Ezra M, Heckenbach I, Andreasson LM, Eriksen LL, Dyhre-Petersen N, Damgaard MV, Berglind M, Pricolo L, Sampson D, Dellinger RW, Sverrild A, Treebak JT, Ditlev SB, Porsbjerg C, Scheibye-Knudsen M |
Nature aging | 2024 |
Fluorescence-activated cell sorting and phenotypic characterization of human fibro-adipogenic progenitors.
Billeskov TB, Jensen JB, Jessen N, Farup J |
2023 | |
ATP and NAD+ Deficiency in Parkinson’s Disease
Mischley LK, Shankland E, Liu SZ, Bhayana S, Fox DJ, Marcinek DJ |
Nutrients | 2023 |
What is really known about the effects of nicotinamide riboside supplementation in humans
Damgaard MV, Treebak JT |
Science Advances | 2023 |
Nicotinamide Riboside, a Promising Vitamin B3 Derivative for Healthy Aging and Longevity: Current Research and Perspectives
Biţă A, Scorei IR, Ciocîlteu MV, Nicolaescu OE, Pîrvu AS, Bejenaru LE, Rău G, Bejenaru C, Radu A, Neamţu J, Mogoşanu GD, Benner SA |
Molecules (Basel, Switzerland) | 2023 |
Lactate: A Theranostic Biomarker for Metabolic Psychiatry?
Caddye E, Pineau J, Reyniers J, Ronen I, Colasanti A |
Antioxidants | 2023 |
NAD + precursor nutritional supplements sensitize the brain to future ischemic events
Qu W, Ralto KM, Qin T, Cheng Y, Zong W, Luo X, Perez-Pinzon M, Parikh SM, Ayata C |
Journal of Cerebral Blood Flow & Metabolism | 2023 |
Dietary Supplementation With NAD+-Boosting Compounds in Humans: Current Knowledge and Future Directions.
Freeberg KA, Udovich CC, Martens CR, Seals DR, Craighead DH |
The journals of gerontology. Series A, Biological sciences and medical sciences | 2023 |
NAD metabolism: Role in senescence regulation and aging.
Chini CCS, Cordeiro HS, Tran NLK, Chini EN |
Aging Cell | 2023 |
Five Padua days on muscle and mobility medicine (2024Pdm3) 27 February - 2 March, 2024 at Hotel Petrarca, Thermae of Euganean Hills, Padua, and San Luca Hall, Prato della Valle, Padua, Italy
Zampieri S, Bersch I, Smeriglio P, Barbieri E, Ganassi M, Leeuwenburgh C, Rosati R, Gargiulo P, Pond A, Sweeney HL, Carraro U |
European Journal of Translational Myology | 2023 |
Clinical Trials Targeting Aging
Nielsen JL, Bakula D, Scheibye-Knudsen M |
2022 |